A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Subtypes are widely found in cancer. They are characterized with different behaviors in clinical and molecular profiles, such as survival rates, gene signature and copy number aberrations (CNAs). While cancer ...